The Biomedical Fund will invest in Indonesian health tech and biotech startups.

Healthcare systems are failing BIPOC women, but entrepreneurs are trying to fill some of the gap — if they can get the funding.

Digital health is not disappearing as a market but will get a "harsh reality check" says the head of the MSD venture unit.

Koch Disruptive Technologies has promoted Israel-based director Jon Galitzer to a US managing director role.

Biotech venture capital is shrinking from boomtime highs, but Sakae Asanuma, CEO of Taiho Ventures, says now is a good time to find new novel treatments to back.

The Brazilian education and health provider is expanding its startup investments following a strategic update last year.

Pharmaceutical startups have had a strong start to 2024, showing off areas like psychedelic mental health treatments, radiotherapeutic cancer drugs and medicine for underserved populations.

Japanese pharma firm Taiho has added $100m to its US-based CVC subsidiary, which has a team of five people.

Bauke Anninga was a principal at M Ventures for two years.

The ex-Illumina Ventures employee has launched a VC firm where she will be managing partner.